Tuesday, May 05, 2020 12:25:47 PM
The CVRs were created as part of the Metabasis acquisition in 2008 and shareholders of Metabasis were given the CVRs along with other consideration just in case some of the assets in Metabasis generated value in the future. Some have worked out and paid out some value, others have not paid any value.
There is a shareholder rep from Metabasis that is responsible for looking after the CVR holders. His name is David Hale and here is his email. dfhale@biopharmaventures.com
There are four CVRs that came from the Metabasis transaction. They trade publicly. Here is the list with a tidbit of info about each:
TRBeta CVR is ticker LGNZZ. This is related to the TRBeta programs at our partner Viking
Glucagon CVR is ticker LGNXZ. This is related to the GRA program at our partner Metavant
General CVR is ticker LGNYZ. A catch all for another couple assets.
Roche CVR is ticker LGNDZ . This is related to a collaboration that Roche had with Metabasis related to HCV compounds. The collaboration has been terminated.
Lastly, there is a CVR agreement that governs the terms of the CVRs and it can be found on the SEC website. Link is here:
https://www.sec.gov/Archives/edgar/data/886163/000119312509215910/0001193125-09-215910-index.html
Patrick O'Brien
SVP Investor Relations
Ligand Pharmaceuticals, Inc.
3911 Sorrento Valley Boulevard, Suite 110
San Diego, CA 92121
O: (858) 550-7768
M: (650) 393-0030
Recent LGND News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/26/2024 12:54:39 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/24/2024 11:41:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/24/2024 11:41:15 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/23/2024 09:30:15 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/23/2024 09:27:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/31/2024 01:00:59 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/31/2024 12:56:18 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/28/2024 08:39:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/27/2024 12:15:37 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/22/2024 10:05:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 09:21:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/09/2024 09:52:17 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/09/2024 09:16:22 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2024 08:30:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 09:15:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2024 09:10:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2024 08:02:22 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 07/09/2024 08:52:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 11:38:30 AM
- Lifecore Biomedical Announces Cooperation Agreement with 22NW • GlobeNewswire Inc. • 07/01/2024 12:00:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 06/03/2024 08:03:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/30/2024 08:03:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/18/2024 12:00:48 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 11:59:50 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/17/2024 09:45:03 PM
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM